Trial Condition(s):

Multiple Sclerosis, Relapsing-Remitting

Impact of the BETACONNECT auto-injector on BETASERON therapy adherence and patient satisfaction

Bayer Identifier:

17942

ClinicalTrials.gov Identifier:

NCT02652091

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The primary objective of this study is to assess adherence and persistence to BETASERON therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device).
The secondary objective of this study is to assess patient-reported satisfaction with the BETACONNECT device.

Inclusion Criteria
- Male and females greater than or equal to 18 years of age
- Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS)
- Prescribed BETASERON (note: decision to treat with BETASERON must be made independent of participation in this study)
- Confirmation of insurance coverage for BETASERON treatment
- Access to a personal computer to complete online patient satisfaction survey at Week 6
Exclusion Criteria
- Currently enrolled in a clinical trial or other observational study for Multiple Sclerosis treatment
- Documented substance abuse within the previous 6 months prior to study enrollment
- Any major laboratory value abnormality that the investigator believes would preclude the patient from participating in the study
- Any medical disorder, condition or history that in the opinion of the investigator would impair the patient’s ability to participate in or complete the study
- Pregnant or nursing

Trial Summary

Enrollment Goal
146
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Lubbock, United States, 79430

Status
Completed
 
Locations

Investigative Site

Stratford, United States, 08084

Status
Completed
 
Locations

Investigative Site

Deckerville, United States, 48427

Status
Completed
 
Locations

Investigative Site

Memphis, United States, 38104

Status
Completed
 
Locations

Investigative Site

Tampa, United States, 33609

Status
Completed
 
Locations

Investigative Site

Boca Raton, United States, 33428

Status
Completed
 
Locations

Investigative Site

Teaneck, United States, 07666

Status
Completed
 
Locations

Investigative Site

Round Rock, United States, 78681

Status
Completed
 
Locations

Investigative Site

Fulton, United States, 20759

Status
Completed
 
Locations

Investigative Site

Franklin, United States, 37064

Status
Completed
 
Locations

Investigative Site

Cullman, United States, 35058

Status
Completed
 
Locations

Investigative Site

Lititz, United States, 17543

Status
Completed
 
Locations

Investigative Site

Nashville, United States, 37212

Status
Completed
 
Locations

Investigative Site

Foxboro, United States, 02035

Status
Completed
 
Locations

Investigative Site

Staten Island, United States, 10306

Status
Completed
 
Locations

Investigative Site

New Port Richey, United States, 34653

Status
Completed
 
Locations

Investigative Site

Fairfax, United States, 22031

Status
Completed
 
Locations

Investigative Site

St. Louis, United States, 63131

Status
Completed
 
Locations

Investigative Site

Bala Cynwyd, United States, 19004

Status
Completed
 
Locations

Investigative Site

Atlanta, United States, 30309-1465

Status
Completed
 
Locations

Investigative Site

Medford, United States, 97504

Status
Completed
 
Locations

Investigative Site

Virginia Beach, United States

Status
Completed
 
Locations

Investigative Site

Medford, United States

Status
Completed
 

Trial Design